Abstract:Backgrounds Anti‐N‐methyl‐D‐aspartate receptor encephalitis (NMDAR‐E) is a severe autoimmune disorder characterized by prominent psychiatric symptoms. Although the role of NMDAR antibodies in the disease has been extensively studied, the phenotype of B cell subsets is still not fully understood. Methods We utilized single‐cell RNA sequencing, single‐cell B cell receptor sequencing (scBCR‐seq), bulk BCR sequencing, flow cytometry, and Enzyme‐Linked Immunosorbent Assay to analyze samples from both NMDAR‐E patients and control individuals. Results The cerebrospinal fluid (CSF) of NMDAR‐E patients showed significantly increased B cell counts, predominantly memory B (Bm) cells. CSF Bm cells in NMDAR‐E patients exhibited upregulated expression of differential expression genes (DEGs) associated with immune regulatory function (TNFRSF13B and ITGB1), whereas peripheral B cells upregulated DEGs related to antigen presentation. Additionally, NMDAR‐E patients displayed higher levels of IgD‐CD27‐ double negative (DN) cells and DN3 cells in peripheral blood (PB). In vitro, DN1 cell subsets from NMDAR‐E patients differentiated into DN2 and DN3 cells, while CD27+ and/or IgD+B cells (non‐DN) differentiated into antibody‐secreting cells (ASCs) and DN cells. NR1‐IgG antibodies were found in B cell culture supernatants from patients. Differential expression of B cell IGHV genes in CSF and PB of NMDAR‐E patients suggests potential antigen class switching. Conclusion B cell subpopulations in the CSF and PB of NMDAR‐E patients exhibit distinct compositions and transcriptomic features. In vitro, non‐DN cells from NMDAR‐E can differentiate into DN cells and ASCs, potentially producing NR1‐IgG antibodies. Further research is necessary to investigate the potential contribution of DN cell subpopulations to NR1‐IgG antibody production. This article is protected by copyright. All rights reserved.

Blood and CSF Findings of Cellular Immunity in Anti-Nmdar Encephalitis.

Extreme Delta Brush Guides to the Diagnosis of Anti-Nmdar Encephalitis

Anti-N-methyl-D-aspartate Receptor Encephalitis: a Prospective Study Focused on Cerebrospinal Fluid and Clinical Symptoms

Single-cell analyses of CSF and PBMCs from anti-NMDAR encephalitis patients reveals distinct characteristics of T cell subpopulations

Inflammatory Markers of Hemogram Parameters As Predictive Factors for Disease Severity in Anti-N-methyl-d-aspartate Receptor Encephalitis.

CSF Findings in Patients with Anti-N-methyl-d-aspartate Receptor-Encephalitis.

Clinical Analysis in Patients with Anti-N-methyl-d-aspartate Receptor Encephalitis

Single‐cell RNA sequencing reveals diverse B cell phenotypes in patients with anti‐NMDAR encephalitis

Single-cell transcriptomics reveals cell type–specific immune regulation associated with anti-NMDA receptor encephalitis in humans

Activation and clonal expansion of CD8+T cells in patients with anti-NMDAR encephalitis revealed by single-cell RNA sequencing analysis

Analysis of Relation Between Electroclinical Features and Cerebrospinal Fluid Antibody Titers in Patients With anti-NMDAR Encephalitis.

Cytokines/Chemokines: Potential Biomarkers for Non-paraneoplastic Anti-N-Methyl-D-Aspartate Receptor Encephalitis

Cerebrospinal Fluid CD20 Positive B-cell Expansion in a Case of Anti-Nmdar Encephalitis

Identification of Medium-Length Antineurofilament Autoantibodies in Patients with Anti-N-Methyl-D-Aspartate Receptor Encephalitis

Anti-NMDAR antibodies, the blood–brain barrier, and anti-NMDAR encephalitis

Study of B Cell Repertoire in Patients With Anti-N-Methyl-D-Aspartate Receptor Encephalitis

High Level of Soluble CD146 in Cerebrospinal Fluid Might Be a Biomarker of Severity of Anti-N-Methyl-D-Aspartate Receptor Encephalitis.

Severity anti-N-methyl-D-aspartate receptor encephalitis:review of clinical presentation,imaging and electroencephalogram

Serum Systemic Autoantibodies in Anti-N-Methyl-D-Aspartate Receptor Encephalitis

Gut microbiome changes in anti-N-methyl-D-aspartate receptor encephalitis patients

Amyloid and Tau as cerebrospinal fluid biomarkers in anti-N-Methyl-D-aspartate receptor encephalitis